These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9081126)

  • 1. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
    J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally applied antisense oligonucleotide to proliferating cell nuclear antigen inhibits intimal thickening in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Ann Vasc Surg; 1998 Sep; 12(5):412-7. PubMed ID: 9732417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
    Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
    J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
    Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
    Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
    Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
    Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
    J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
    Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
    J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
    Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
    Davies MG; Klyachkin ML; Dalen H; Svendsen E; Hagen PO
    Surgery; 1993 Aug; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of endothelium-derived relaxing factor-mediated relaxation and smooth muscle cell function in arterial and venous vein bypass grafts.
    Davies MG; Klyachkin ML; Svendsen E; Hagen PO
    Cardiovasc Surg; 1996 Apr; 4(2):150-60. PubMed ID: 8861428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
    Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
    J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Trovato MJ; Barber L; Safi HJ; Hagen PO
    J Surg Res; 1999 Jun; 84(2):223-32. PubMed ID: 10357924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.